Lifemd (LFMD) closed at $2.23 on October 28, 2026, up 5.2% from the previous close, on volume of 681,672 shares (30-day average 679,622).
Data as of October 28, 2026.
LifeMD to Report Third Quarter 2026 Financial Results on November 9
Globe Newswire (Tue, 20-Oct 4:05 PM ET)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Globe Newswire (Tue, 22-Sep 5:01 PM ET)
AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD
PRNewswire (Tue, 15-Sep 9:01 AM ET)
UPDATE - LifeMD Reports Second Quarter 2026 Results
Globe Newswire (Wed, 5-Aug 7:45 PM ET)
LifeMD Reports Second Quarter 2026 Results
Globe Newswire (Wed, 5-Aug 4:11 PM ET)
LifeMD Builds AI-Focused Leadership Team, Appoints New CFO With Deep Healthcare Finance Experience
Market Chameleon (Mon, 16-Mar 7:44 AM ET)
Market Chameleon (Tue, 10-Mar 6:32 AM ET)
LifeMD Appoints Dr. Tara Scott as Ambassador to Bolster Comprehensive Women’s Health Program
Market Chameleon (Wed, 22-Oct 5:36 AM ET)
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of October 29, 2026, LFMD stock price climbed to $2.39 with 545,948 million shares trading.
LFMD has a beta of 1.35, meaning it tends to be more sensitive to market movements. LFMD has a correlation of 0.06 to the broad based SPY ETF.
LFMD has a market cap of $115.33 million. This is considered a Micro Cap stock.
Last quarter Lifemd reported $47 million in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.08.
In the last 3 years, LFMD traded as high as $15.84 and as low as $2.06.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): VTI, IWM, VXF, KOMP, VTWO.
LFMD has underperformed the market in the last year with a return of -61.1%, while the SPY ETF gained +12.9%. In the last 3 month period, LFMD fell short of the market, returning -37.8%, while SPY returned +3.9%. However, in the most recent 2 weeks LFMD has outperformed the stock market by returning +0.8%, while SPY returned -0.2%.
LFMD support price is $2.14 and resistance is $2.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.